The Headline Everyone’s Reading
The numbers look impressive. U.S. Customs and Border Protection seized 27,000 pounds of fentanyl at ports of entry in fiscal year 2025, a jump of 34 percent from the previous year. When that figure crossed my desk, my first instinct was the same as it probably was for yours: that’s a win. More drugs stopped. Fewer pills on the street. Fewer overdoses.
Then I picked up the phone and called three people I trust in this space. A DEA analyst. A public health researcher. Someone who actually counts bodies for the coroner’s office. What they told me was more complicated than any headline could capture.
The Seizure Stat Doesn’t Measure What You Think It Does
Here’s what makes this tricky. A seizure number tells you what agents found and stopped. It does not tell you how much fentanyl the cartels actually wanted to move. It does not tell you supply. It does not tell you what made it through.
The DEA’s own estimates are instructive: approximately 90 percent of fentanyl enters through legal ports of entry, typically hidden in vehicles or concealed in luggage and cargo. That means the seizures we celebrate are happening at chokepoints designed specifically for inspection. The real question is whether the administration’s approach is affecting the 90 percent that slips through, or whether we’re just getting better at catching what cartels have decided to sacrifice as a cost of doing business.
Consider the tariff announcement from February 2025. The administration imposed 25 percent tariffs on Mexican goods, partly justified on fentanyl trafficking grounds. High-profile move. But when you separate the theater from the mechanics, you’re left with a policy that targets trade rather than trafficking infrastructure. The cartels don’t care about tariffs. They care about routes. And they’ve got plenty of routes.
The Death Toll Trend Complicates the Victory Narrative
This is where the human story actually lives. The CDC reported 80,000 overdose deaths in 2025, down from a peak of 111,000 in 2023. That decline is real. That’s lives. But the attribution matters enormously, and it’s where the conversation gets political in ways that obscure actual public health progress.
Health officials credit the decline partly to wider naloxone distribution programs that expanded under the Biden administration. Naloxone is the overdose reversal drug that emergency responders and now everyday people carry. Its availability saved lives. These programs are now being scaled back under the new administration. When I dug into the CDC Drug Overdose Data, what I found was a story about prevention, not interdiction. The border seizures and the overdose decline are not the same story.
A researcher I contacted put it plainly: a fentanyl user who survives an overdose because someone nearby has naloxone is saved by access to medication, not by what happens at a port of entry in El Paso. Both matter. But they’re different levers, and we keep describing them as if they’re one thing.
The Ground-Level Operations Tell a Different Story
Operation Blue Lotus, the joint DEA-DHS initiative launched in September 2025, made 1,400 arrests across 22 states targeting fentanyl distribution networks. That’s the kind of operation that actually disrupts how drugs move through American cities. It’s domestic enforcement, not border enforcement. That distinction matters because it’s easy to conflate the two.
Border seizures are headline-friendly. They’re visible. You can photograph a table covered in packages. Distribution network arrests are quieter. They happen in living rooms and parking lots across the country. They require sustained coordination that budget cuts make harder. When you talk to the DEA analysts who actually run these operations, they’ll tell you they’re doing more with less. They’ll also tell you it’s not sustainable.
The CBP Drug Seizure Statistics show one picture. The arrest data from Blue Lotus shows another. Neither is complete without the other.
The Complication From Mexico Changes the Calculus
In January 2026, Mexico’s President Claudia Sheinbaum released her government’s figures at a press conference. Her numbers showed 43 metric tons of fentanyl precursors interdicted in 2025. When data from allied nations starts diverging this significantly, something important is happening. Either the measurement methods are different. Or the story each side wants to tell is different. Or both.
The reality is that the fentanyl crisis exists in both countries. It’s manufactured in Mexico using precursors sourced from China and India, trafficked north, and it kills Americans. But the policy response from Washington keeps treating it as primarily a border issue, when the supply chain begins much earlier and much further away.
What I’ve learned over years of reporting is that numbers are honest only if you ask them honest questions. The 34 percent increase in seizures is real. The decline in overdose deaths is real. The arrests are real. But take them together and you’re looking at a system doing multiple things at once, some effective and some less so, and we’re not having a clear conversation about which is which.
What Happens When You Keep Asking
The story isn’t that the seizure numbers are wrong or that the administration is lying about them. The story is that seizing more fentanyl at the border while scaling back the programs that keep people alive when they use it is a choice. A policy choice. And whether it’s working requires looking at outcomes in the places where people actually use drugs and die from them, not just at totals at the border.
If you have information from your local community about how these changes are landing on the ground, I’d like to hear it. Send me a line. I’ve got my police scanner running and I’m making calls. I want to get this story right.